Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study

BACKGROUND: Fenofibrate offers a number of benefits on the cardiovascular system and it is plausible that its anti-inflammatory, anti-oxidant and anti-fibrotic effects and enhancement of cardiac metabolic performances may account for its direct cardioprotective effects. In this study we aimed to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Nita, Cristina, Bala, Cornelia, Porojan, Mihai, Hancu, Nicolae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974011/
https://www.ncbi.nlm.nih.gov/pubmed/24594096
http://dx.doi.org/10.1186/1758-5996-6-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974011/
https://www.ncbi.nlm.nih.gov/pubmed/24594096
http://dx.doi.org/10.1186/1758-5996-6-30

Ejemplares similares